December 21, 2016 / 10:50 PM / 8 months ago

BRIEF-Amicus Therapeutics issued $250 mln aggregate principal amount of 3 pct convertible senior notes due 2023

Dec 21 (Reuters) - Amicus Therapeutics Inc

* issued $250 million aggregate principal amount of 3.00 pct convertible senior notes due 2023 -SEC filing

* Notes will mature on December 15, 2023

* Used a portion of net proceeds from note offering to pay cost of capped call transactions

* Notes bear interest at fixed rate of 3.00 pct per year, payable semiannually on June 15, Dec 15 of each year, beginning June 2017

* Also used approximately $88.2 million of net proceeds from note offering to refinance existing unsecured debt Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below